Bortezomib resistance can be reversed by induced expression of plasma cell maturation markers in a mouse in vitro model of multiple myeloma.

PloS one

Volumn 8, Issue 10, 2013, Pages

  Stessman, Holly A F ^a   Mansoor, Aatif ^b   Zhan, Fenghuang ^b   Linden, Michael A ^b   Van Ness, Brian ^b   Baughn, Linda B ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BORONIC ACID DERIVATIVE; BORTEZOMIB; CD69 ANTIGEN; LECTIN; LEUKOCYTE ANTIGEN; PYRAZINE DERIVATIVE; T LYMPHOCYTE ANTIGEN;

ANIMAL; ARTICLE; DRUG EFFECT; DRUG RESISTANCE; HUMAN; METABOLISM; MOUSE; MULTIPLE MYELOMA; PATHOLOGY; PHYSIOLOGY; PLASMA CELL; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BIOLOGICAL MARKERS; BORONIC ACIDS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; HUMANS; LECTINS, C-TYPE; MICE; MULTIPLE MYELOMA; PLASMA CELLS; PYRAZINES;

EID: 84905294644     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077608     Document Type: Article

References (0)